US Patent 10464952 Beta-lactamase inhibitors
Patent 10464952 was granted and assigned to Venatorx Pharmaceuticals Inc. on November, 2019 by the United States Patent and Trademark Office.
Is a
Date Filed
June 7, 2018
Date of Patent
November 5, 2019
Patent Application Number
16002363
Patent Citations
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10464952 Beta-lactamase inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
